Found 54 results
Filters: Author is J. Chen  [Clear All Filters]
P. Hu, Hu, B., Qin, Y. H., Lu, L., Li, Z. Q., Tao, L. Q., Pei, Q., and Chen, J., Serum lipid abnormalities are not associated with apoB 3' VNTR polymorphism in nephrotic children, vol. 12, pp. 765-774, 2013.
Bairaktari E, Hatzidimou K, Tzallas C, Vini M, et al. (2000). Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin. Biochem. 33: 549-555.   Batanian JR, Ledbetter DH and Fenwick RG (1998). A simple VNTR-PCR method for detecting maternal cell contamination in prenatal diagnosis. Genet. Test. 2: 347-350. PMid:10464615   Boerwinkle E, Xiong WJ, Fourest E and Chan L (1989). Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region. Proc. Natl. Acad. Sci. U. S. A. 86: 212-216. PMid:2911570 PMCid:286434   Choong ML, Koay ES, Khaw MC and Aw TC (1999). Apolipoprotein B 5'-Ins/Del and 3'-VNTR polymorphisms in Chinese, malay and Indian singaporeans. Hum. Hered. 49: 31-40. PMid:9858855   Cohen SL, Cramp DG, Lewis AD and Tickner TR (1980). The mechanism of hyperlipidaemia in nephrotic syndrome--role of low albumin and the LCAT reaction. Clin. Chim. Acta 104: 393-400.   Deka R, Chakraborty R, DeCroo S, Rothhammer F, et al. (1992). Characteristics of polymorphism at a VNTR locus 3' to the apolipoprotein B gene in five human populations. Am. J. Hum. Genet. 51: 1325-1333. PMid:1463014 PMCid:1682919   Destro-Bisol G, Presciuttini S, d'Aloja E, Dobosz M, et al. (1994). Genetic variation at the ApoB 3'HVR, D2S44, and D7S21 loci in the Ewondo Ethnic Group of Cameroon. Am. J. Hum. Genet. 55: 168-174. PMid:7912886 PMCid:1918238   Dixit M, Srivastava A, Choudhuri G and Mittal B (2008). Higher alleles of apolipoprotein B Gene 3' VNTR: risk for gallstone disease. Ind. J. Clin. Biochem. 23: 123-129. PMid:23105737 PMCid:3453088   Dixit VM and Hettiaratchi ES (1979). The mechanism of hyperlipidaemia in the nephrotic syndrome. Med. Hypotheses 5: 1327-1331.   Friedl W, Ludwig EH, Paulweber B, Sandhofer F, et al. (1990). Hypervariability in a minisatellite 3' of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls. J. Lipid Res. 31: 659-665. PMid:2351870   Gipson DS, Massengill SF, Yao L, Nagaraj S, et al. (2009). Management of childhood onset nephrotic syndrome. Pediatrics 124: 747-757. PMid:19651590   Gong WK, Cheung W and Yap HK (2000). Minimal change nephrotic syndrome - a complex genetic disorder. Ann. Acad. Med. Singapore 29: 351-356. PMid:10976389   Gordillo R and Spitzer A (2009). The nephrotic syndrome. Pediatr. Rev. 30: 94-104. PMid:19255123   Hansen PS, Gerdes LU, Klausen IC, Gregersen N, et al. (1993). Polymorphisms in the apolipoprotein B-100 gene contributes to normal variation in plasma lipids in 464 Danish men born in 1948. Hum. Genet. 91: 45-50. PMid:8095917   Hokken-Koelega AC, Hackeng WH, Stijnen T, Wit JM, et al. (1990). Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J. Clin. Endocrinol. Metab 71: 688-695. PMid:2394775   Hu P, Lu L, Hu B and Du PF (2009a). Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome. Scand. J. Clin. Lab. Invest. 69: 680-686. PMid:19468931   Hu P, Qin YH, Jing CX, Lei FY, et al. (2009b). Association of polymorphisms at restriction enzyme recognition sites of apolipoprotein B and E gene with dyslipidemia in children undergoing primary nephrotic syndrome. Mol. Biol. Rep. 36: 1015-1021. PMid:18512131   Hu P, Qin YH, Jing CX, Lu L, et al. (2009c). Effect of apolipoprotein B polymorphism on body mass index, serum protein and lipid profiles in children of Guangxi, China. Ann. Hum. Biol. 36: 411-420. PMid:19449275   Hu P, Qin YH, Hu B and Lu L (2010). Hypervariability in a minisatellite 3' of the apolipoprotein B gene: allelic distribution and influence on lipid profiles in Han Children from central China. Clin. Chim. Acta 411: 2092-2096. PMid:20837003   Hu P, Wang J, Hu B, Lu L, et al. (2012). Dyslipidemia acts as a close link between cardiovascular risk and renal progression in nephrotic children. Asian Biomed. 6: 151-157.   Huang LS and Breslow JL (1987). A unique AT-rich hypervariable minisatellite 3' to the ApoB gene defines a high information restriction fragment length polymorphism. J. Biol. Chem. 262: 8952-8955. PMid:2885324   Khrunin A, Verbenko D, Nikitina K and Limborska S (2007). Regional differences in the genetic variability of Finno- Ugric speaking Komi populations. Am. J. Hum. Biol. 19: 741-750. PMid:17691096   Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, et al. (2004). The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr. Nephrol. 19: 744-748. PMid:15085419   Mitsnefes MM (2008). Cardiovascular complications of pediatric chronic kidney disease. Pediatr. Nephrol. 23: 27-39. PMid:17120060 PMCid:2100430   Noguera NI, Tallano CE, Bragos IM and Milani AC (2000). Modified salting-out method for DNA isolation from newborn cord blood nucleated cells. J. Clin. Lab. Anal. 14: 280-283.<280::AID-JCLA6>3.0.CO;2-0   Pan JP, Chiang AN, Chou CY, Chan WL, et al. (1998). Polymorphisms of the apolipoprotein B 3' variable number of tandem repeats region associated with coronary artery disease in Taiwanese. J. Formos. Med. Assoc. 97: 233-238. PMid:9585673   Pontrelli L, Sidiropoulos KG and Adeli K (2004). Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions. Biochemistry 43: 6734-6744. PMid:15157107   Rantala M, Rantala TT, Savolainen MJ, Friedlander Y, et al. (2000). Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet. Am. J. Clin. Nutr. 71: 713-724. PMid:10702164   Rebhi L, Omezzine A, Kchok K, Belkahla R, et al. (2008). 5' ins/del and 3' VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease. Clin. Chem. Lab. Med. 46: 329-334. PMid:18254714   Ruf RG, Wolf MT, Hennies HC, Lucke B, et al. (2003). A gene locus for steroid-resistant nephrotic syndrome with deafness maps to chromosome 14q24.2. J. Am. Soc. Nephrol. 14: 1519-1522. PMid:12761252   Ruixing Y, Guangqin C, Yong W, Weixiong L, et al. (2007). Effect of the 3'APOB-VNTR polymorphism on the lipid profiles in the Guangxi Hei Yi Zhuang and Han populations. BMC Med. Genet. 8: 45. PMid:17640344 PMCid:1939985   Sajantila A, Lukka M and Syvanen AC (1999). Experimentally observed germline mutations at human micro- and minisatellite loci. Eur. J. Hum. Genet. 7: 263-266. PMid:10196715   Segrest JP, Jones MK, De Loof H and Dashti N (2001). Structure of apolipoprotein B-100 in low density lipoproteins. J. Lipid Res. 42: 1346-1367. PMid:11518754   Soares-Vieira JA, Billerbeck AE, Iwamura ES, Cardoso L, et al. (2000). Post-mortem forensic identity testing: application of PCR to the identification of fire victim. Sao Paulo Med. J. 118: 75-77. PMid:10810332   Tovar AR, Murguia F, Cruz C, Hernandez-Pando R, et al. (2002). A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J. Nutr. 132: 2562-2569. PMid:12221209   Verbenko DA, Pogoda TV, Spitsyn VA, Mikulich AI, et al. (2003). Apolipoprotein B 3'-VNTR polymorphism in Eastern European populations. Eur. J. Hum. Genet. 11: 444-451. PMid:12774037   Wiecek A, Kokot F, Strzelczyk P, Witkowicz J, et al. (1993). Relationship between renal biopsy histopathology and profile of changes in serum protein, lipids and proteinuria in patients with nephrotic syndrome due to chronic glomerulonephritis. Pol. Arch. Med. Wewn. 90: 426-432. PMid:8146046   Yasuda N and Kimura M (1968). A gene-counting method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems. Ann. Hum. Genet. 31: 409-420. PMid:5673164
J. Chen, Wang, H. Y., and Zeng, C. Y., Transcriptome network analysis of potential candidate genes for heart failure, vol. 12, pp. 4687-4697, 2013.
X. - Q. Dong, Du, Q., Yu, W. - H., Zhang, Z. - Y., Zhu, Q., Che, Z. - H., Wang, H., Chen, J., Yang, S. - B., and Wen, J. - F., Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with C-reactive protein in Chinese Han patients with spontaneous basal ganglia hemorrhage, vol. 11, pp. 1841-1850, 2012.
Al-Daghri N, Chetty R, McTernan PG, Al-Rubean K, et al. (2005). Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovasc. Diabetol. 4: 10. PMid:15998471 PMCid:1183229   Bokarewa M, Nagaev I, Dahlberg L, Smith U, et al. (2005). Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174: 5789-5795. PMid:15843582   Brown R, Thompson HJ, Imran SA, Ur E, et al. (2008). Traumatic brain injury induces adipokine gene expression in rat brain. Neurosci. Lett. 432: 73-78. PMid:18178314 PMCid:2367125   Cho YM, Youn BS, Chung SS, Kim KW, et al. (2004). Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47: 559-565. PMid:14740159   Dong XQ, Hu YY, Yu WH and Zhang ZY (2010a). High concentrations of resistin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. J. Crit. Care 25: 243-247. PMid:19903588   Dong XQ, Yang SB, Zhu FL, Lv QW, et al. (2010b). Resistin is associated with mortality in patients with traumatic brain injury. Crit. Care 14: R190. PMid:21029428 PMCid:3219297   Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, et al. (2007). Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin. Chim. Acta 378: 78-85. PMid:17173885   Fasshauer M, Klein J, Neumann S, Eszlinger M, et al. (2001). Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 288: 1027-1031. PMid:11689013   Hivert MF, Manning AK, McAteer JB, Dupuis J, et al. (2009). Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes 58: 750-756. PMid:19074981 PMCid:2646076   Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, et al. (2003). Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 309: 286-290. PMid:12951047   Kawanami D, Maemura K, Takeda N, Harada T, et al. (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun. 314: 415-419. PMid:14733921   Kothari RU, Brott T, Broderick JP, Barsan WG, et al. (1996). The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27: 1304-1305. PMid:8711791   Lin XJ, Zhang YD, Guan QS, Di Q, et al. (2007). Plasma resistin levels and single-nucleotide polymorphisms in resistin gene 5' flanking region in patients with stroke. Chin. Med. Sci. J. 22: 27-32. PMid:17441314   Lu SC, Shieh WY, Chen CY, Hsu SC, et al. (2002). Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 530: 158-162.   Osawa H, Yamada K, Onuma H, Murakami A, et al. (2004). The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am. J. Hum. Genet. 75: 678-686. PMid:15338456 PMCid:1182055   Osawa H, Tabara Y, Kawamoto R, Ohashi J, et al. (2007). Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 30: 1501-1506. PMid:17384338   Pang SS and Le YY (2006). Role of resistin in inflammation and inflammation-related diseases. Cell. Mol. Immunol. 3: 29-34. PMid:16549046   Piestrzeniewicz K, Luczak K and Goch JH (2009). Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men. Cardiol. J. 16: 36-42. PMid:19130414   Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, et al. (2005). Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932-939. PMid:15710760   Shetty GK, Economides PA, Horton ES, Mantzoros CS, et al. (2004). Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27: 2450-2457. PMid:15451915   Silswal N, Singh AK, Aruna B, Mukhopadhyay S, et al. (2005). Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 334: 1092-1101. PMid:16039994   Steppan CM, Bailey ST, Bhat S, Brown EJ, et al. (2001a). The hormone resistin links obesity to diabetes. Nature 409: 307-312. PMid:11201732   Steppan CM, Brown EJ, Wright CM, Bhat S, et al. (2001b). A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. U. S. A. 98: 502-506. PMid:11209052 PMCid:14616   Tsukahara T, Nakashima E, Watarai A, Hamada Y, et al. (2009). Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res. Clin. Pract. 84: 179-186. PMid:19269054   Ukkola O, Kunnari A and Kesaniemi YA (2008). Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul. Pept. 149: 56-59. PMid:18440081   Wiesner G, Brown RE, Robertson GS, Imran SA, et al. (2006). Increased expression of the adipokine genes resistin and fasting-induced adipose factor in hypoxic/ischaemic mouse brain. Neuroreport 17: 1195-1198. PMid:16837853   Wilkinson M, Brown R, Imran SA and Ur E (2007). Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 86: 191-209. PMid:17878708   Yoshino T, Kusunoki N, Tanaka N, Kaneko K, et al. (2011). Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern. Med. 50: 269-275. PMid:21325757
B. C. Jiang, Kaleri, H. A., Zhang, H. X., Chen, J., and Liu, H. L., Application of the Sleeping Beauty system in Saanen goat fibroblast cells for establishing persistent transgene expression, vol. 10, pp. 3347-3355, 2011.
Bruder JT and Kovesdi I (1997). Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J. Virol. 71: 398-404. PMid:8985363 PMCid:191064   Chen H, Lan XY, Li RB, Lei CZ, et al. (2005). The effect of CSN1 S2, CSN3 and beta-lg genes on milk performance in Xinong Saanen dairy goat. Yi Chuan Xue Bao 32: 804-810. PMid:16231734   Cole GM, Bell L, Truong QB and Saitoh T (1992). An endosomal-lysosomal pathway for degradation of amyloid precursor protein. Ann. N. Y. Acad. Sci. 674: 103-117. PMid:1288357   Davidson AE, Gratsch TE, Morell MH, O'Shea KS, et al. (2009). Use of the Sleeping Beauty transposon system for stable gene expression in mouse embryonic stem cells. Cold Spring Harb. Protoc. 2009: db.   Dupuy AJ, Fritz S and Largaespada DA (2001). Transposition and gene disruption in the male germline of the mouse. Genesis 30: 82-88. PMid:11416868   Dupuy AJ, Clark K, Carlson CM, Fritz S, et al. (2002). Mammalian germ-line transgenesis by transposition. Proc. Natl. Acad. Sci. U. S. A. 99: 4495-4499. PMid:11904379 PMCid:123676   Fischer SE, Wienholds E and Plasterk RH (2001). Regulated transposition of a fish transposon in the mouse germ line. Proc. Natl. Acad. Sci. U. S. A. 98: 6759-6764. PMid:11381141 PMCid:34426   Gordon EM and Anderson WF (1994). Gene therapy using retroviral vectors. Curr. Opin. Biotechnol. 5: 611-616.   Horie K, Kuroiwa A, Ikawa M, Okabe M, et al. (2001). Efficient chromosomal transposition of a Tc1/mariner- like transposon Sleeping Beauty in mice. Proc. Natl. Acad. Sci. U. S. A. 98: 9191-9196. PMid:11481482 PMCid:55396   Ivics Z, Hackett PB, Plasterk RH and Izsvak Z (1997). Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510.   Jaenisch R, Dausman J, Cox V and Fan H (1976). Infection of developing mouse embryos with murine leukemia virus: tissue specificity and genetic transmission of the virus. Hamatol. Bluttransfus. 19: 341-356. PMid:1010468   Kovesdi I, Brough DE, Bruder JT and Wickham TJ (1997). Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol. 8: 583-589.   Latchman DS (1994). Herpes simplex virus vectors for gene therapy. Mol. Biotechnol. 2: 179-195. PMid:7866875   Li Y, Wu KF, Guo XD, Guo JT, et al. (2002). Optimization of parameters of exogene transfection of bovine fetal fibroblasts in vitro mediated by liposome. Yi Chuan 24: 653-655. PMid:15979962   Naldini L (1998). Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9: 457- 463.   Padeh B, Wyskoki M and Soller M (1971). Further studies on a Robertsonian translocation in the Saanen dairy goat. Cytogenetics 10: 61-69. PMid:5107073   Patterson GH and Lippincott-Schwartz J (2002). A photoactivatable GFP for selective photolabeling of proteins and cells. Science 297: 1873-1877. PMid:12228718   Rabinowitz JE and Samulski J (1998). Adeno-associated virus expression systems for gene transfer. Curr. Opin. Biotechnol. 9: 470-475.   Thierry AR, Rabinovich P, Peng B, Mahan LC, et al. (1997). Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA. Gene Ther. 4: 226-237. PMid:9135736   Yant SR, Meuse L, Chiu W, Ivics Z, et al. (2000). Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. 25: 35-41. PMid:10802653   Zhu J, Park CW, Sjeklocha L, Kren BT, et al. (2010). High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene. Biochemistry 49: 1507-1521. PMid:20041635 PMCid:2822882